Sign Up Today and Learn More About Caribou Biosciences Stock

Invest in or calculate the value of your shares in Caribou Biosciences or other pre-IPO companies through EquityZen's platform.

Get Started

Caribou Biosciences Stock

Biotechnology company specializing in genome engineering

About Caribou Biosciences Stock




Berkeley, CA, US

Notable Investor

F-Prime Capital Partners

Total Funding


Caribou Biosciences is a biotechnology company in genome engineering. We develop technology-based solutions for cellular engineering and analysis based on the CRISPR-Cas9 technology platform. Cas9, when paired with a guide RNA, cuts double-stranded DNA allowing for specific changes to DNA. These site-specific DNA modifications can be utilized to carry out sophisticated gene knock-outs or knock-ins.

Investors in Caribou Biosciences

Discover investors in Caribou Biosciences stock and explore their portfolio companies

Caribou Biosciences Management

Leadership team at Caribou Biosciences


Jennifer A. Doudna


James Berger

Locked Features

Join now and verify your accreditation status to gain access to:

  • Caribou Biosciences current valuation
  • Caribou Biosciences stock price
  • Available deals in Caribou Biosciences and all other companies
  • Deal offering documents
  • EquityZen's proprietary data and insights, including
    • Cap tables, which include funding history by Share Class and Liquidity Preferences
    • Company Highlights
    • Business Model
    • Risk Factors
Join Now

How to invest in Caribou Biosciences stock?

Accredited investors can buy pre-IPO stock in companies like Caribou Biosciences through EquityZen funds. These investments are made available by existing Caribou Biosciences shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.

How to sell Caribou Biosciences stock?

Shareholders can sell their Caribou Biosciences stock through EquityZen's private company marketplace. EquityZen's network includes over 310K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.

If I invest, how do I exit my investment?

There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.

Why choose EquityZen?

Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 41K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."